NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 332 filers reported holding NATERA INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,014,697 | -8.1% | 22,931 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $1,104,631 | -15.5% | 22,701 | -3.6% | 0.00% | 0.0% |
| Q1 2023 | $1,307,940 | +189.1% | 23,558 | +109.2% | 0.00% | 0.0% |
| Q4 2022 | $452,354 | -67.6% | 11,261 | -64.6% | 0.00% | -50.0% |
| Q3 2022 | $1,395,000 | +13.6% | 31,830 | -8.1% | 0.00% | +100.0% |
| Q2 2022 | $1,228,000 | +1.3% | 34,642 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,212,000 | -70.2% | 34,499 | -20.7% | 0.00% | -75.0% |
| Q4 2021 | $4,061,000 | -29.7% | 43,487 | -16.2% | 0.00% | -33.3% |
| Q3 2021 | $5,780,000 | -0.9% | 51,865 | +1.0% | 0.01% | 0.0% |
| Q2 2021 | $5,832,000 | +7.3% | 51,369 | -4.0% | 0.01% | 0.0% |
| Q1 2021 | $5,434,000 | -3.5% | 53,519 | -5.4% | 0.01% | 0.0% |
| Q4 2020 | $5,631,000 | +32.9% | 56,584 | -3.5% | 0.01% | +20.0% |
| Q3 2020 | $4,236,000 | +9.7% | 58,633 | -24.3% | 0.01% | 0.0% |
| Q2 2020 | $3,863,000 | -15.8% | 77,482 | -49.6% | 0.01% | +25.0% |
| Q1 2020 | $4,588,000 | +80.4% | 153,664 | +103.6% | 0.00% | +33.3% |
| Q4 2019 | $2,543,000 | +14.1% | 75,489 | +11.1% | 0.00% | 0.0% |
| Q3 2019 | $2,229,000 | – | 67,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |